Abstract
The laboratory diagnosis of Clostridioides difficile infection (CDI) is challenging since this bacteria may be detected in healthy people and toxin production detection is not sensitive enough to be used alone. Thus, there is no single test with adequate sensitivity and specificity to be used in laboratory diagnosis. We evaluated the performance of tests used in the diagnosis of CDI in symptomatic patients with risk factors in hospitals in southern Brazil. Enzyme immunoassays (EIA) for glutamate dehydrogenase antigen (GDH) and toxins A/B, real-time polymerase chain reaction (qPCR), GeneXpert system, and a two-step algorithm comprising GDH/TOXIN EIA performed simultaneously followed by GeneXpert for outliers were evaluated. Toxigenic strain in stool culture was considered CDI positive (gold standard). Among 400 samples tested, 54 (13.5%) were positive for CDI and 346 (86.5%) were negative. The diagnosis of the two-step algorithm and qPCR had an excellent performance with an accuracy of 94.5% and 94.2%, respectively. The Youden index showed that GeneXpert as a single test (83.5%) and the two-step algorithm (82.8%) were the most effective assays. Diagnosing CDI and non-CDI diarrhea could be successfully attained by the combination of clinical data with accuracy of laboratory tests.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this published article.
References
Leffler DA, Lamont JT (2015) Clostridium difficile infection. N Engl J Med 372:1539–1548. https://doi.org/10.1056/NEJMra1403772
Schäffler H, Breitrück A (2018) Clostridium difficile - from colonization to infection. Front Microbiol 9:646. https://doi.org/10.3389/fmicb.2018.00646/full
LC MD, Killgore GE, Thompson A et al (2005) An Epidemic, toxin gene–variant strain of Clostridium difficile. N Engl J Med 353:2433–2441. https://doi.org/10.1056/NEJMoa051590
Wei C, Wwen-en L, Yang-ming L et al (2015) Diagnostic accuracy of loop-mediated isothermal amplification in detection of Clostridium difficile in stool samples: a meta-analysis. Arch Med Sci 11:927–936. https://doi.org/10.5114/aoms.2015.54846
Crobach MJ, Planche T, Eckert C et al (2016) European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect 22:s63–s81. https://doi.org/10.1016/j.cmi.2016.03.010
McDonald LC, Gerding DN, Johnson S et al (2018) Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 66:e1–e48. https://doi.org/10.1093/cid/cix1085
Carroll KC, Mizusawa M (2020) Laboratory tests for the diagnosis of Clostridium difficile. Clin Colon Rectal Surg 33:73–81. https://doi.org/10.1055/s-0039-3400476
Cohen SH, Gerding DN, Johnson S et al (2010) Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31:431–455
Crobach MJT, Baktash A, Duszenko N (2018) Kuijper EJ Diagnostic guidance for C. difficile infections. Adv Exp Med Biol 1050:27–44. https://doi.org/10.1007/978-3-319-72799-8_3
Burnham CAD, Carroll KC (2013) Diagnosis of clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 26:604–630
Fang FC, Polage CR, Wilcox MH (2017) Point-counterpoint: what is the optimal approach for detection of Clostridium difficile infection? J Clin Microbiol 55:670–680
Delmée M (2001) Laboratory diagnosis of Clostridium difficile disease. Clin Microbiol. Infect 7:411–416. https://doi.org/10.1046/j.1198-743x.2001.00294.x
Hall GS (2016) Anaerobic Bacteriology, Clinical microbiology procedures handbook, 4th edn. ASM Press, Washington, DC, pp 807–813
Wroblewski D, Hannett GE, Bopp DJ et al (2009) Rapid molecular characterization of Clostridium difficile and assessment of populations of C . difficile in stool specimens. J Clin Microbiol 47:2142–2148. https://doi.org/10.1128/JCM.02498-08
Maestri AC, Raboni SM, Cogo LL et al (2021) Standardisation and validation of an in-house quantitative real-time polymerase chain reaction (qPCR) assay for the diagnosis of Clostridioides difficile infection. J Microbiol Methods 193:106399. https://doi.org/10.1016/j.mimet.2021.106399
Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20(1):37–46. https://doi.org/10.1177/001316446002000104
Youden WJ, Steiner EH (1975) Statistical manual of the AOAC—Association of the Official Analytical Chemists. AOAC-I, Washington DC
Planche TD, Davies KA, Coen PG et al (2013) Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C. difficile infection. Lancet Infect Dis 13:936–945. https://doi.org/10.1016/S1473-3099(13)70200-7
Bouza E, Aguado JM, Alcalá L et al (2020) Recommendations for the diagnosis and treatment of Clostridioides difficile infection: an official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR). Rev Esp Quimioter 33:151–175 https://pubmed.ncbi.nlm.nih.gov/32080996/
Reller ME, Lema CA, Perl TM et al (2007) Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol 45:3601–3605. https://doi.org/10.1128/JCM.01305-07
Shetty N, Wren NMW, Coen PG (2011) The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysis. J Hosp Infect 77:1–6. https://doi.org/10.1016/j.jhin.2010.07.024
Gerding DN et al (1986) Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med 146 https://pubmed.ncbi.nlm.nih.gov/3942469/:95–100
Humphries RM, Uslan DZ, Rubin Z (2013) Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity. J. Clin Miicrobiol 51:869–873. https://doi.org/10.1128/JCM.02970-12
Wilcox MH, Planche T, Fan FC et al (2010) What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection? J Clin Microbiol 48:4347–4353. https://doi.org/10.1128/JCM.02028-10
Mundy LS, Shanholtzer CJ, Willard KE et al (1995) Laboratory detection of Clostridium difficile. A comparison of media and incubation systems. Am J Clin Pathol 103:52–56. https://doi.org/10.1093/ajcp/103.1.52
Hink T, Burnham CA, Dubberke ER (2013) A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens. Anaerobe 19:39–43. https://doi.org/10.1016/j.anaerobe.2012.12.001
Edwards AN, Karim ST, Pascua RA et al (2016) Chemical and stress resistances of Clostridium difficile spores and vegetative cells. Front Microbiol 7:1698. https://doi.org/10.3389/fmicb.2016.01698
Stamper PD, Alcabasa R, Aird D et al (2009) Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol 47(2):373–378. https://doi.org/10.1128/JCM.01613-08
Mehlig M, Moos M, Braun V et al (2001) Variant toxin B and a functional toxin A produced by Clostridium difficile C34. FEMS Microbiol Lett 198:171–176. https://doi.org/10.1111/j.1574-6968.2001.tb10638.x
Jensen MB, Olsen KE, Nielsen XC et al (2015) Diagnosis of Clostridium difficile: real-time PCR detection of toxin genes in faecal samples is more sensitive compared to toxigenic culture. Eur J Clin Microbiol Infect Dis 34:727–736. https://doi.org/10.1007/s10096-014-2284-7
Barbut F, Braun M, Burghoffer B et al (2009) Rapid detection of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR. J Clin Microbiol 47:1276–1277. https://doi.org/10.1128/JCM.00309-09
Gould CV, Edwards JR, Cohen J et al (2013) Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis 57:1304–1307. https://doi.org/10.1093/cid/cit492
Kraft CS, Parrott JS, Cornish NE et al (2019) A laboratory medicine best practices systematic review and meta-analysis of nucleic acid amplification tests (NAATs) and algorithms including NAATs for the diagnosis of Clostridioides (Clostridium) difficile in adults. Clin Microbiol Rev 32:e00032–e00018. https://doi.org/10.1128/CMR.00032-18
Rinttilä T, Kassinen A, Malinen E et al (2004) Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 97:1166–1177. https://doi.org/10.1111/j.1365-2672.2004.02409.x
Grein JD, Ochner MM, Hoang H et al (2014) Comparison of testing approaches for Clostridium difficile infection at a large community hospital. Clin Microbiol Infect 20:65–69. https://doi.org/10.1111/1469-0691.12198
Schrader C, Schielke A, Ellerbroek L et al (2012) PCR inhibitors - occurrence, properties and removal. J Appl Microbiol 113(5):1014–1026. https://doi.org/10.1111/j.1365-2672.2012.05384.x
van Dorp SM, Notermans DW, Albla J et al (2016) European Clostridium difficile infection surveillance network (ECDIS-Net) project on behalf of all participants. Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014. Euro Surveill 21:30292. https://doi.org/10.2807/1560-7917.ES.2016.21.29.30292
Cançado GGL, Abreu ES, Nardelli MJ et al (2021) A cost of illness comparison for toxigenic Clostridioides difficile diagnosis algorithms in developing countries. Anaerobe 70:102390. https://doi.org/10.1016/j.anaerobe.2021.102390
Cançado GGL, Silva ROS, Nader AP et al (2018) Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil. J Gastroenterol Hepatol 33:393–396. https://doi.org/10.1111/jgh.13901
Ramos CP, Lopes EO, Diniz AN et al (2020) Evaluation of glutamate dehydrogenase (GDH) and toxin A/B rapid tests for Clostridioides (prev. Clostridium) difficile diagnosis in a university hospital in Minas Gerais, Brazil. J Microbiol 2020(51):1139–1143. https://doi.org/10.1007/s42770-020-00288-z
Goldenberg SD, Cliff PR, Smith S et al (2010) Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile. J Hosp Infect 74:48–54. https://doi.org/10.1016/j.jhin.2009.08.014
Johansson K, Karlsson H, Norén T (2016) Clostridium difficile infection diagnostics – evaluation of the C. DIFF Quik Chek Complete assay, a rapid enzyme immunoassay for detection of toxigenic C. difficile in clinical stool samples. APMIS 124:1016–1020. https://doi.org/10.1111/apm.12595
Chung HS, Lee M (2017) Evaluation of the performance of C. DIFF QUIK CHEK COMPLETE and its usefulness in a hospital setting with a high prevalence of Clostridium difficile infection. J Investig Med 65:88–92. https://doi.org/10.1111/apm.12595
Camargo TS, Junior MS, Camargo L et al (2021) Clostridioides difficile laboratory diagnostic techniques: a comparative approach of rapid and molecular methods. Arch Microbiol 203:1683–1690. https://doi.org/10.1007/s00203-020-02148-8
Acknowledgements
We are grateful to our colleagues at the Complexo Hospital de Clínicas, Cajuru University Hospital, Hospital das Nações, Hospital Santa Casa, Hospital Ônix, Hospital Erasto Gaertner Hospital do Idoso Zilda Arns, Hospital São Vicente, and Hospital Infantil Pequeno Príncipe, who provided the samples and clinical data and assisted with the research.
Funding
This research was supported by a Brazilian Research Program for the Unified Health System: Management Shared Health—PPSUS 2015 edition—Fundação Araucária-PR/SESA-PR/CNPq/MS-Decit.
Author information
Authors and Affiliations
Contributions
All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The Institutional Research and Ethics Committee approved the study, and the need for informed consent was waived for all participating patients (CEAE = 59027716.5.1001.0096).
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Responsible Editor: Fernando R. Pavan
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Maestri, A.C., Nogueira, K.S., Mialski, R. et al. Laboratory diagnosis of Clostridioides difficile infection in symptomatic patients: what can we do better?. Braz J Microbiol 54, 849–857 (2023). https://doi.org/10.1007/s42770-023-00956-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42770-023-00956-w